Suzhou, China

Lu Wang

This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Midea Group Co., Ltd., Soochow University, Guangdong Midea White Home Appliance Technology Innovation Center Co., Ltd.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lu Wang. Retrieved from https://idiyas.com/inventor/lu-wang-f9ts35h1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0


Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Foshan, CN (2023)
  • Suzhou, CN (2024)

Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Lu Wang

Introduction

Lu Wang is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative anti-tumor treatments. With a total of 5 patents, his work focuses on enhancing the efficacy of cancer therapies.

Latest Patents

One of Lu Wang's latest patents is titled "Anti-tumor platinum-based drug mineralized protein nanoparticle, preparation method therefor and use thereof." This invention discloses anti-tumor platinum drug mineralized protein nanoparticles that include a platinum drug and a protein. The protein can be selected from albumin, transferrin, hemoglobin, and low-density lipoprotein. The platinum drugs involved in this invention include cisplatin, iodoplatin, bromoplatin, oxaliplatin, carboplatin, or nedaplatin, with a drug loading of 1% to 50%.

Another significant patent is "Recombinant viral vector, immune composition containing same, and use thereof." This invention provides a recombinant viral vector and an immunogenic composition that enhances cellular immune responses to target immunogens. The recombinant viral vector comprises a polynucleotide encoding a fusion peptide of CD4 helper T cell epitopes, which can improve immune responses, particularly to weak immunogens.

Career Highlights

Lu Wang has worked with prominent companies such as Midea Group Co., Ltd. and Jiangsu Midea Cleaning Appliances Co., Ltd. His experience in these organizations has contributed to his expertise in the field of innovative drug development.

Collaborations

Lu Wang has collaborated with notable individuals in his field, including Jin Wang and Hyun Seon Shin, who is a woman. These collaborations have likely enriched his research and development efforts.

Conclusion

Lu Wang's innovative contributions to cancer treatment through his patents demonstrate his commitment to advancing medical science. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…